Compare Snowflake Inc (SNOW) vs Tilray Brands Inc (TLRY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Snowflake Inc vs Tilray Brands Inc — how do they compare? Snowflake Inc trades at $368.89 (market cap $121.15B), while Tilray Brands Inc trades at $3.54 (market cap $530.54M). The key difference: Snowflake Inc is far larger — about 228.4× Tilray Brands Inc's market cap, and Snowflake Inc is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Snowflake Inc for 54 Days and Tilray Brands Inc for 31 Days on average.
| SNOW | TLRY | |
|---|---|---|
Market Cap | $121.15B | $530.54M |
Volume | 3,986,549 | 9,099,075 |
Sector | Technology | Health |
52-Week High | $368.89 | $17.20 |
52-Week Low | $121.11 | $3.54 |
Typical Hold Time | 54 Days | 31 Days |
Enterprise Value | $121.57B | $684.46M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Snowflake (SNOW) trades at $343.40, up 3.17% with strong technical momentum and bullish moving average signals. The company shows impressive revenue growth from $1.2B in 2022 to $3.63B in 2025, though it remains unprofitable with a -20.07% net margin. Recent earnings beats and a $3.75B convertible note offering highlight strategic positioning in the AI data cloud market. Analyst consensus is strongly bullish with 81% buy ratings and a $418 price target, representing 22% upside potential.
Snowflake presents a growth-over-profits investment case with expanding revenue and market leadership in data cloud services. Key opportunities include AI integration partnerships and enterprise adoption, while risks center on persistent losses, high valuation multiples (P/S 21.75), and competitive pressure from cloud giants. The stock's technical strength and Wall Street optimism suggest continued upside if execution matches growth expectations.
Tilray Brands (TLRY) trades at $3.59, down 3.36% on the day and near 52-week lows, with bearish technical indicators dominating. The company reported $821 million in revenue for 2025 but posted a massive $2.19 billion net loss due to impairment charges. Recent earnings have consistently missed expectations, though analyst consensus remains cautiously optimistic with a $65.01 price target. The stock faces significant headwinds from ongoing profitability challenges and cannabis industry volatility.
TLRY presents a high-risk opportunity with potential upside if management can achieve profitability and capitalize on cannabis reform catalysts. However, persistent losses, negative cash flow, and competitive pressures create substantial downside risk. Investors should weigh the speculative nature against potential regulatory catalysts in the coming months.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Snowflake Inc
Founded in 2012, Snowflake is a data lake, warehousing, and sharing company that came public in 2020. To date, the company has over 3,000 customers including nearly 30% of the Fortune 500 as its customers. Snowflake's data lake stores unstructured and semistructured data that can then be used in analytics to create insights stored in its data warehouse. Snowflake's data sharing capability allows enterprises to easily buy and ingest data almost instantaneously compared with a traditionally months-long process. Overall, the company is known for the fact that all of its data solutions that can be hosted on various public clouds.
Read more on SNOW →About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →
